Nephrology
Hospital  >  Departments  >  Medicine  >  Divisions  >  Nephrology  >  Research & clinical trials
Share:  
|
PAGE
MENU

Research & clinical trials

Member research

Our members participate in nephrology research. Please visit their profile pages or our research showcase to learn more about our members and their work.

Clinical trials

We work with the following clinical trials:

Peer reviewed

  • HSFO: HARMONY study
    Hypertension Analysis of Stress Reduction using Mindfulness Meditation & Yoga 
  • CIHR: STARRT-AKI
    Standard versus Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury.
  • CANNeCTIN  Atrial Fibrillation and Hypertension study
    Canadian Kidney Knowledge Translation and Generation Network (CANN-NET)
  • CIHR/AstraZeneca: HOPE3
    The HOPE-3 trial evaluates the effects of statin therapy to lower cholesterol, low dose angiotensin-receptor blocker plus diuretic therapy to lower blood pressure (blood pressure) and combined cholesterol and BP lowering with these drugs in a wide range of subjects at risk, targeted for primary prevention, who are already receiving lifestyle advice.  
  • CIHR: CURCUMIN study
    Curcumin to Prevent Perioperative Complications From Elective Abdominal Aortic Aneurysm Repair: A Randomized Controlled Trial 
  • ARTEMIS registry for ABPM
    International Ambulatory Blood Pressure Registry: Telemonitoring of Hypertension and Cardiovascular Risk Project 
  • NIH: NEPTUNE
    Nephrotic Syndrome Study Network, Longitudinal control
  • NIH: CORAL
    Cardiovascular Outcomes in Renal Atherosclerotic Lesions Randomized and Multi-Center Two-Group Clinical Trial to Assess The Best Treatment for Patients with High Blood Pressure and Renal Artery Stenosis: Stenting with Anti-Hypertensive Medical Therapy, Compared to Medical Therapy Alone

Industry sponsored

  • Janssen: CANPREDICT
    CANadian study of Prediction of Risk and Evolution to Dialysis, Death and Interim Cardiovascular events over 
  • Astra/Zeneca/Brigham and Women's:
    TIMI53 SAVOR (Diabetic nephropathy)Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IVTrial to Evaluate the Effect of Saxagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischaemic Stroke in Patients with Type 2 Diabetes 
  • Janssen: PRO STARRT
    A Prospective, Observational, Randomized Comparative Study of Case Managed Versus Non-case Managed Initiation of Hemodialysis
  • Novartis: APOLLO study
    Aliskiren Prevention of Later Life Outcomes Trial: A randomized controlled trial of Aliskiren in the Prevention of major cardiovascular events in elderly people

Quick links

Contact us »

Nephrology division

Sunnybrook Health Sciences Centre
Kidney Care Centre at the CNIB Centre
1929 Bayview Ave., 3rd floor
Toronto, ON M4G 3E8

Phone:
416-480-6100 ext. 3863

Email:
mary.coates@
sunnybrook.ca

Division Head:
Dr. Michelle Hladunewich


Appointments »

All appointments (including questions about, or changes to appointments) MUST be coordinated by your care team. Clinic patients are now seen at the CNIB Satellite Centre, with the exception of the HIV Renal Disease Clinic, and the Pregnancy and Kidney Disease (PreKID) Clinic; these two clinics remain at Sunnybrook's (main) Bayview Campus.

Clinics »

Meet our team »

Patient education » 

Physician education »

Refer a patient »

Each of our clinics manage their own referral process. Please refer to our clinic information page for referral details and documentation requirements.

Research & trials »